Training in 21st century medicine must be aimed at creating health team leaders. They must be able to work closely with other professionals, understand population health and health policy, and know how to work within the social and economic constraints now reshaping their industry.
Despite its title, “Improving Diagnosis in Health Care,” you have to dig deep into the Institute of Medicine's first-ever report on the problem of misdiagnosed patients to find proposals that will have an immediate impact on the problem.
With President Barack Obama pushing his Precision Medicine Initiative, and a slew of new genetic diagnostic tests entering the market, it's worth revisiting the recent payment history for PET scans, the go-go imaging technology whose use exploded in the early 2000s.
Congress is back in session. The fact-free political campaign season lies ahead. What better time to offer a special themed edition of Modern Healthcare's Data Points feature as background for an issue dominating the headlines?
Want to bring down a hospital's patient-satisfaction scores in a hurry? Let the physician practices operating inside that hospital slap patients with surprise charges after they've unwittingly been seen by an out-of-network physician.
Over the several years that the CMS and hospitals have been tussling over the reasons behind the steady rise in short-term observation stays, no one until now has suggested the increase represents a deliberate effort by hospitals to avoid Medicare's 30-day readmission penalties.
The latest Kaiser Family Foundation tracking poll showed most Americans are more concerned about the rising price of drugs than repeal of the Affordable Care Act. But drug prices are not the only cost issue on peoples' minds.
Anyone concerned about unnecessary healthcare spending—and what system leader or insurer isn't these days?—should pay close attention to the drug industry's campaign to win the right to promote the off-label use of prescription drugs.
It doesn't matter how much healthcare providers and researchers rail about the inadequacy and inconsistency of the consumer ratings offered by the CMS, the Leapfrog Group, journalism outfits and online startups. They are not only here to stay, they are proliferating.
In what must have been a terrible disappointment for Obamacare bashers on the presidential campaign trail, the early returns from California suggest the rate increases next year in the individual and small-group health insurance market will be modest. The news comes with a caveat: Everything may...
The United States finances healthcare through a confusing hodgepodge of payment programs that send distorted signals to employers, insurers, providers and the general public.
Later this year, the U.S. Bureau of Labor Statistics will issue its first report measuring hospital productivity. It won't be good news.